ETC
NBIX icon

Exchange Traded Concepts’s Neurocrine Biosciences NBIX Stock Holding History

Exchange Traded Concepts’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$719K Buy
4,268
+386
+10% +$57.3K ﹤0.01% 1035
2026
Q1 		$511K Sell
3,882
-553
-12% -$73.4K ﹤0.01% 994
2025
Q4 		$629K Buy
4,435
+2,641
+147% +$383K ﹤0.01% 969
2025
Q3 		$252K Sell
1,794
-5,369
-75% -$727K ﹤0.01% 1166
2025
Q2 		$900K Buy
7,163
+136
+2% +$15.6K 0.01% 720
2025
Q1 		$777K Sell
7,027
-1,106
-14% -$140K 0.01% 687
2024
Q4 		$1.11M Buy
8,133
+169
+2% +$20.9K 0.02% 522
2024
Q3 		$918K Buy
7,964
+1,803
+29% +$247K 0.02% 548
2024
Q2 		$848K Buy
6,161
+429
+7% +$58.8K 0.02% 494
2024
Q1 		$791K Sell
5,732
-1,479
-21% -$202K 0.02% 492
2023
Q4 		$950K Buy
7,211
+26
+0.4% +$2.99K 0.03% 413
2023
Q3 		$808K Sell
7,185
-53
-0.7% -$5.58K 0.02% 433
2023
Q2 		$683K Sell
7,238
-222
-3% -$21.7K 0.02% 487
2023
Q1 		$755K Sell
7,460
-1,210
-14% -$126K 0.02% 368
2022
Q4 		$1.04M Buy
8,670
+147
+2% +$17.2K 0.03% 306
2022
Q3 		$905K Sell
8,523
-429
-5% -$43.5K 0.03% 291
2022
Q2 		$873K Buy
8,952
+552
+7% +$50.9K 0.03% 313
2022
Q1 		$788K Sell
8,400
-2,880
-26% -$244K 0.02% 374
2021
Q4 		$961K Buy
11,280
+5,130
+83% +$472K 0.02% 346
2021
Q3 		$590K Buy
6,150
+5,610
+1,039% +$530K 0.02% 452
2021
Q2 		$53K Sell
540
-229
-30% -$21.9K ﹤0.01% 871
2021
Q1 		$75K Sell
769
-316
-29% -$33.1K ﹤0.01% 765
2020
Q4 		$104K Buy
+1,085
New +$105K ﹤0.01% 665
2020
Q2 		– Sell
-29
Closed -$3K – 832
2020
Q1 		$3K Buy
+29
New +$2.84K ﹤0.01% 454

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Exchange Traded Concepts's NBIX Position: Q2 2026 in Review

Exchange Traded Concepts increased its Neurocrine Biosciences (NBIX) stake by 9.9% in Q2 2026, buying an estimated $57.3K and bringing the position to 4,268 shares worth $719K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Exchange Traded Concepts first reported a position in NBIX in Q1 2020 and has held it in 24 quarters since. The position peaked at $1.11M in Q4 2024. 154 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Exchange Traded Concepts held 4,268 shares of Neurocrine Biosciences worth $719K as of Q2 2026.
  • Exchange Traded Concepts bought 386 Neurocrine Biosciences shares in Q2 2026, an estimated $57.3K.
  • Neurocrine Biosciences made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1035 holding.
  • Exchange Traded Concepts first reported a position in Neurocrine Biosciences in Q1 2020 and has held it in 24 quarters since.
  • Exchange Traded Concepts's Neurocrine Biosciences position peaked at $1.11M in Q4 2024.
  • 154 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.